Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/7988
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alihanoglu, Y.I. | - |
dc.contributor.author | Doğu Kılıç, İsmail | - |
dc.contributor.author | Yildiz, B.S. | - |
dc.date.accessioned | 2019-08-16T12:34:05Z | - |
dc.date.available | 2019-08-16T12:34:05Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1304-3889 | - |
dc.identifier.uri | https://hdl.handle.net/11499/7988 | - |
dc.description.abstract | Acute coronary syndromes (ACS) are one of the leading causes of death and morbidity in industrialized countries. Typical presentation includes acute chest pain, cardiac troponin elevation and possibly associated electrocardiogram abnormalities. In great majority of the cases, myocardial infarction (MI) is due to atherosclerosis, usually with plaque rupture and consequent vessel occlusion. However, a minority of patients may suffer an MI for a range of other rare reasons such as coronary vasospasm, coronary thrombosis in situ or embolization from a distal source, hypercoagulable states, spontaneous coronary dissection, some coronary anomalies including coronary bridges and inflammatory states. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | European Journal of General Medicine | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Acute coronary syndrome | en_US |
dc.subject | Myocardial bridge | en_US |
dc.subject | Non-atherosclerosis | en_US |
dc.subject | acetylsalicylic acid | en_US |
dc.subject | anticoagulant agent | en_US |
dc.subject | antithrombin | en_US |
dc.subject | antivitamin K | en_US |
dc.subject | beta adrenergic receptor blocking agent | en_US |
dc.subject | blood clotting factor 12 | en_US |
dc.subject | blood clotting factor 5 Leiden | en_US |
dc.subject | C reactive protein | en_US |
dc.subject | calcium channel blocking agent | en_US |
dc.subject | clopidogrel | en_US |
dc.subject | diuretic agent | en_US |
dc.subject | estrogen receptor | en_US |
dc.subject | fibrinogen | en_US |
dc.subject | fibrinogen receptor antagonist | en_US |
dc.subject | glycoprotein IIb | en_US |
dc.subject | glycoprotein IIIa | en_US |
dc.subject | heparin | en_US |
dc.subject | hydroxymethylglutaryl coenzyme A reductase inhibitor | en_US |
dc.subject | immunoglobulin | en_US |
dc.subject | magnesium | en_US |
dc.subject | nitrate | en_US |
dc.subject | plasminogen activator inhibitor 1 | en_US |
dc.subject | progesterone | en_US |
dc.subject | protein C | en_US |
dc.subject | protein S | en_US |
dc.subject | thienopyridine derivative | en_US |
dc.subject | tissue plasminogen activator | en_US |
dc.subject | acute coronary syndrome | en_US |
dc.subject | artery embolism | en_US |
dc.subject | cardiovascular inflammation | en_US |
dc.subject | cardiovascular mortality | en_US |
dc.subject | cardiovascular risk | en_US |
dc.subject | cardiovascular stent | en_US |
dc.subject | conservative treatment | en_US |
dc.subject | coronary artery anomaly | en_US |
dc.subject | coronary artery bypass graft | en_US |
dc.subject | coronary artery dissection | en_US |
dc.subject | coronary artery embolism | en_US |
dc.subject | coronary artery obstruction | en_US |
dc.subject | coronary artery spasm | en_US |
dc.subject | coronary artery thrombosis | en_US |
dc.subject | coronary inflammation | en_US |
dc.subject | drug abuse | en_US |
dc.subject | drug megadose | en_US |
dc.subject | estrogen therapy | en_US |
dc.subject | heart transplantation | en_US |
dc.subject | human | en_US |
dc.subject | hypercoagulability | en_US |
dc.subject | molecular pathology | en_US |
dc.subject | morbidity | en_US |
dc.subject | mucocutaneous lymph node syndrome | en_US |
dc.subject | myocardial bridging | en_US |
dc.subject | percutaneous coronary intervention | en_US |
dc.subject | protein expression | en_US |
dc.subject | protein function | en_US |
dc.subject | review | en_US |
dc.subject | risk assessment | en_US |
dc.subject | smoking | en_US |
dc.subject | thorax pain | en_US |
dc.subject | venous thromboembolism | en_US |
dc.subject | vitamin supplementation | en_US |
dc.title | Non-atherosclerotic causes of acute coronary syndrome and management of the patients | en_US |
dc.type | Review | en_US |
dc.identifier.volume | 10 | en_US |
dc.identifier.issue | SUPPL.1 | en_US |
dc.identifier.startpage | 22 | - |
dc.identifier.startpage | 22 | en_US |
dc.identifier.endpage | 31 | en_US |
dc.authorid | 0000-0002-5270-3897 | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.scopus | 2-s2.0-84883876937 | en_US |
dc.identifier.wos | WOS:000421916400006 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.openairetype | Review | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.fulltext | With Fulltext | - |
item.languageiso639-1 | en | - |
item.grantfulltext | open | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
non-atherosclerotic-causes-of-acute-coronary-syndromeand-management-of-the-patients-7090.pdf | 188.03 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
2
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
1
checked on Nov 22, 2024
Page view(s)
32
checked on Aug 24, 2024
Download(s)
16
checked on Aug 24, 2024
Google ScholarTM
Check
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.